News
GHRH analog
GH Pulsatility Research: How GHRH and GHRP Secretagogues Synergize
How GH pulsatility research separates GHRH-receptor and GHSR-1a secretagogue pathways in preclinical peptide study design.
Read moreGHRH analog
CJC-1295 and Ipamorelin Blend: How Dual GHRH/GHRP Signaling Is Studied in Research
CJC-1295 and Ipamorelin blend research: how combining a GHRH analog with a selective GHRP is...
Read moreGHRH analog
Sermorelin Peptide: How the Shortest Bioactive GHRH Fragment Is Studied in Research
The Sermorelin peptide is the minimal GHRH(1-29) fragment retaining full receptor activity. Here's what research...
Read moreGHRH analog
Peptide Half-Life and Stability: How Structural Modifications Change Research Outcomes
Peptide half-life and stability depend on structural modifications like DAC albumin conjugation, terminal capping, and...
Read moreGHRH analog
CJC-1295 With DAC vs. Without DAC: Comparing Half-Life and Receptor-Binding Research Profiles
CJC-1295 with DAC vs. without DAC comes down to a single structural addition that changes...
Read moreGHRH analog
Sermorelin vs. Ipamorelin vs. CJC-1295: Comparing GH Secretagogue Peptides in Research
Sermorelin vs Ipamorelin vs CJC-1295: a research-framed comparison of how each peptide engages the GHRH...
Read moreGHRH analog
Tesamorelin Peptide: How It Works — and How It Stacks Up Against CJC-1295
Tesamorelin is a GHRH analog built to outlast native GHRH in circulation. Here's the receptor...
Read more